Teleflex Incorporated (NYSE:TFX) Stock Holdings Lessened by Blue Trust Inc.

Blue Trust Inc. cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 51.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 153 shares of the medical technology company’s stock after selling 159 shares during the period. Blue Trust Inc.’s holdings in Teleflex were worth $27,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TFX. Avior Wealth Management LLC boosted its stake in shares of Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares during the period. Ashton Thomas Securities LLC purchased a new stake in shares of Teleflex during the third quarter worth $40,000. True Wealth Design LLC boosted its position in Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after purchasing an additional 166 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in Teleflex during the third quarter valued at $54,000. Finally, Banque Cantonale Vaudoise grew its stake in Teleflex by 184.8% in the third quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 146 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Down 21.8 %

Shares of Teleflex stock opened at $138.99 on Friday. Teleflex Incorporated has a 12-month low of $135.95 and a 12-month high of $249.90. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a 50 day moving average price of $176.35 and a two-hundred day moving average price of $205.70. The stock has a market capitalization of $6.46 billion, a P/E ratio of 27.63, a PEG ratio of 1.73 and a beta of 1.16.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. Teleflex’s dividend payout ratio is currently 27.04%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on TFX. Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Truist Financial cut their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Finally, Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $246.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.